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Each month, Chemistry & Biology Select highlights a selection of research reports from the recent
literature. These highlights are a snapshot of interesting research done across the field of chemical
biology. Thismonth’s Select highlights two achievements from the realmof synthetic biology, a new
way of targeting adipocytes and a view into how membrane lipids modulate ion channels.Elani et al. describe vesicle-based artificial cells with multiple compartments with distinct
regions separated from one another by a lipid bilayer. Each step of an enzymatic cascade
reaction takes place in a discrete compartment, with the products moving into an adjacent
compartment to initiate subsequent reaction steps. Image courtesy of Yuval Elani and
coworkers.Compartmentalizing
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Compartmentalization in biological
systems plays an important role in
allowing the spatial and temporal sepa-
ration of different biological processes
needed for function. For those inter-
ested in building artificial cells,
achieving compartmentalization is
thus a critical problem. In biology,
most basic compartmentalization is
achieved using systems of lipid bilayer
membranes that form different com-
partments. One design strategy for
creating artificial cells in synthetic
biology uses similar building blocks.
In brief, vesicle-based artificial cells
are generated using water-in-oil droplets that are transferred from oil to aqueous solution, thus attaining the bilayer via the
phase transfer process. A similar approach can be used to generate multicompartment vesicles in which adjacent vesicles
share a joint internal bilayer.
The key characteristic of the biological compartments is their ability to enclose specific, well-defined components and
exchange information. From an artificial cell design perspective, this is a nontrivial issue and one that Elani et al. address
by generating multicompartment vesicles and isolating different chemical steps within each vesicle. The three chemical steps
that Elani et al. use to create a model for a signaling cascade are conversion of lactose to glucose catalyzed by lactase, fol-
lowed by the generation of H2O2 from glucose using glucose oxidase, and, finally, oxidation of a dye by H2O2 to a fluorescent
product, resorufin, mediated by horseradish peroxidase. The three reactions took place in three separate vesicles. In order to
ensure that glucose, the product of the first reaction, is in the second vesicle, Elani et al. introduce a-hemolysin pores into the
vesicle’s bilayer, which allowed diffusion of glucose. Given that H2O2 freely diffuses across lipid bilayers, no special adjust-
ments need to be made to ensure its transport. The authors successfully demonstrate that resorufin was produced and that
vesicles stay stable during the course of the reaction cascade. These results are a step towards realizing a functional artificial
cell and a proof of principle that different chemical transformations can be combined into a cascade using multicompartment
vesicles.
Elani et al. (2014). Nat. Commun. Published online October 29, 2014. http://dx.doi.org/10.1038/ncomms6305.Watch Out Obesity, Here Comes the Gene Therapy
News of the world-wide obesity epidemic is often on the front page. As the averageweight of theworld’s population continues
to rise, so does the number of obesity-associated conditions, all of which requiremajor and/or sustainedmedical intervention.
This makes finding safe antiobesity treatment options a priority for both academic researchers and pharmaceutical industry.
Weight gain and accumulation of white adipocytes are hallmarks of obesity, and oneway of getting around some of the issues
with antiobesity drugs that control appetite is to develop drugs that target adipocytes. Earlier attempts at adipocyte-targeted
gene therapy have demonstrated that this approach would be a viable strategy, providing that safe and selective delivery of
the therapeutic gene(s) becomes available.
This is the problem that Won et al. tackle. They use previously identified adipocyte-targeting oligopeptide sequence (ATS),
which binds prohibitin on adipocyte surface and gets internalized, to generate a gene carrier that incorporates the ATS, the
D-form 9-arginine cell penetrating peptide (9R), and the shRNA targeting fatty-acid binding protein-4 (shFABP4). Won et al.Chemistry & Biology 21, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1417
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Selectdemonstrate that prohibitin is located on the surface of mature adipocytes and that it binds ATS-9R carrying a DNA oligopep-
tide cargo. They show that the cargo is internalized in prohibitin and ATS-dependent fashion and that it is specific for adipo-
cytes. When diet-induced obesity (DIO) mice, which were shown to have increased levels of prohibitin on their adipocytes,
were given ATS-9R/shFABP4, the mice experienced a 70% decrease in levels of FABP4, resulting in improved insulin sensi-
tivity, reduced blood glucose levels, and significant weight loss. Although the physiological effects are clear, a number of
mechanistic questions related to ATS-9R penetration and internalization remain open and await future studies. For now,
the work suggests that adipocyte-targeted gene therapy might be on the horizon.
Won et al. (2014). Nat. Mater. Published October 5, 2014. http://dx.doi.org/10.1038/NMAT4092.Phosphatidic Acid Is an Active Player in KV Physiology
Voltage-gated potassium channels, KVs, are transmembrane proteins that sense the change in the membrane potential and
open to let the K+ ions flow out of the cell to extracellular space or close to prevent this passage. In addition to the membrane
potential, other factors have been reported to regulate the gating of KVs, including the membrane lipid composition and the
specific phospholipid species of which the plasma membrane is made.
To examine this link between the channel gating and membrane lipid composition more systematically, Hite et al. analyze
the behavior of a model KV channel reconstituted into planar bilayers with varying lipid compositions. What they see is that the
presence of palmitoyl oleyl phosphatidic acid (POPA) in the bilayer has a large effect on gating. Additional analysis let Hite
et al. conclude that phosphatidic acid (PA) is behind this effect and that it impacts the gating via two different mechanisms.
PA is a negatively chargedmolecule and it is primarily found in the inner leaflet of the membrane. This asymmetric distribution
of PA gives rise to surface charge voltage offset, and this effect is also seen when other similarly charged lipids are used and
can therefore be viewed as generic. However, Hite et al. also observe an additional ‘‘PA-specific’’ effect, seen as the large shift
in the half-activation voltage produced by POPA located in the intracellular leaflet. They suggest that the specific effect is likely
due to electrostatic interaction between PA and a specific arginine guanidinium group located on the S4 helix of the voltage
sensor that results in stabilization of the closed conformation. The study provides an interesting view of PA as an active player
in modulation of KV channel activity and leads the authors to propose that this might be a way in which lipid metabolism is
linked to regulation of the transmembrane potential.
Hite et al. (2014) eLife. Published online October 6, 2014. http://dx.doi.org/10.7554/eLife.04366.Protease-Based Signaling Circuits and More
One of the goals of synthetic biology is to design de novo signaling networks and use them to achieve specific functional and
technological outcomes. Proteins are core building blocks of practically all biological signaling networks, and they have been
receiving a lot of attention as the desirable design components for generating synthetic signaling circuits. But the progress
has been slow due to some fundamental challenges of engineering protein-based methods of regulation, both allosteric
and proximity based.
Stein and Alexandrov approach this problem by exploiting protease-based signaling as the basis for developing artificial
signal transducers, receptors, sensors, and circuits. Their elementary signal transducing unit is made of an artificial autoinhi-
bited protease module that was generated by fusing a protease of interest, NIa protease from tobacco vein mottling virus
(TVMV) and NS3 serine protease from hepatitis C virus (HCV), to an autoinhibitor (AI) developed from the protease target pep-
tide sequence. This module would be inactive under basal conditions, with AI bound into the protease active site. Upon
receiving a specific signal, such as the cleavage of the linker between the protease and AI, the AI dissociates, autoinhibition
is lifted, and the protease is activated and ready for inducing downstream signaling. The two proteases used here, TVMV and
HCV, are naturally orthogonal; the authors were able to combine them and form an integrated signal sensing and amplification
circuit using a TVMV-based signal sensor and an HCV-based signal transducer, as well as create a protease-based proximity
sensor. The current results are promising and open the doors for the follow upwork that will need to include the demonstration
of how artificial signaling cascades using protease-based modules function in vivo.
Stein and Alexandrov (2014). Proc. Natl. Acad. Sci. USA. Published online October 29, 2014. http://dx.doi.org/10.1073/
pnas.1405220111.
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